Canada markets closed

ImmunityBio, Inc. (IBRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.06+0.14 (+1.77%)
At close: 04:00PM EDT
7.95 -0.11 (-1.37%)
After hours: 07:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.36B
Enterprise Value 5.82B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)6.48k
Price/Book (mrq)N/A
Enterprise Value/Revenue 9.36k
Enterprise Value/EBITDA -13.35

Trading Information

Stock Price History

Beta (5Y Monthly) -0.23
52-Week Change 3253.51%
S&P500 52-Week Change 326.43%
52 Week High 310.53
52 Week Low 31.25
50-Day Moving Average 35.93
200-Day Moving Average 33.71

Share Statistics

Avg Vol (3 month) 37.31M
Avg Vol (10 day) 318.88M
Shares Outstanding 5677.04M
Implied Shares Outstanding 6677.04M
Float 8145.27M
% Held by Insiders 179.25%
% Held by Institutions 18.80%
Shares Short (Apr 15, 2024) 454.84M
Short Ratio (Apr 15, 2024) 412.1
Short % of Float (Apr 15, 2024) 439.03%
Short % of Shares Outstanding (Apr 15, 2024) 48.10%
Shares Short (prior month Mar 15, 2024) 453.25M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-60,792.80%

Management Effectiveness

Return on Assets (ttm)-52.11%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)622k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)90.40%
Gross Profit (ttm)N/A
EBITDA -342.85M
Net Income Avi to Common (ttm)-583.2M
Diluted EPS (ttm)-1.15
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)266.46M
Total Cash Per Share (mrq)0.4
Total Debt (mrq)883.68M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.05
Book Value Per Share (mrq)-0.88

Cash Flow Statement

Operating Cash Flow (ttm)-366.76M
Levered Free Cash Flow (ttm)-234.66M